Department of Health written question – answered on 15th September 2015.
Alert me about debates like this
To ask the Secretary of State for Health, when he plans to make the dementia drug solanegement available on the NHS.
Solanezumab is still undergoing clinical trials and is not yet licensed for use in the European Union or the United States for the treatment of Alzheimer's disease.
Yes0 people think so
No0 people think not
Would you like to ask a question like this yourself? Use our Freedom of Information site.
Making it easy to keep an eye on the UK’s parliaments. Discover who represents you, how they’ve voted and what they’ve said in debates – simply and clearly.
Get insights on TheyWorkForYou and other mySociety sites, in our popular newsletter
Your donations keep this site and others like it running
mySociety is a registered charity in England and Wales (1076346) and a limited company (03277032). We provide commercial services through our wholly owned subsidiary SocietyWorks Ltd (05798215).